Singh, Harinder <br/><br/>
Nano-formulation of rifampicin with enhanced bioavailability: development, characterization and in-vivo safety.  [electronic resource] 

 -  International journal of pharmaceutics  May 2015 
 - 138-51 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-3476 
<br/><br/><label>Standard No.: </label>10.1016/j.ijpharm.2015.02.050  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Animals<br/>Antibiotics, Antitubercular--administration & dosage<br/>Area Under Curve<br/>Biological Availability<br/>Calorimetry, Differential Scanning<br/>Chemical and Drug Induced Liver Injury--etiology<br/>Chemistry, Pharmaceutical<br/>Crystallography, X-Ray<br/>Dose-Response Relationship, Drug<br/>Drug Carriers<br/>Emulsions<br/>Lethal Dose 50<br/>Lipids--chemistry<br/>Metabolic Clearance Rate<br/>Microscopy, Atomic Force<br/>Microscopy, Electron, Transmission<br/>Nanomedicine<br/>Nanoparticles<br/>Particle Size<br/>Powder Diffraction<br/>Rats, Wistar<br/>Rifampin--administration & dosage<br/>Solubility<br/>Technology, Pharmaceutical--methods